China Healthwise Holdings Limited (HKG:0348)

China Healthwise Holdings Cash Flow Statement

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-40.28	-134.56	-54.27	-103.05
Depreciation & Amortization	7.17	5.62	3.3	4.2
Asset Writedown & Restructuring Costs	0.8	0.32	0.62	3.24
Loss (Gain) From Sale of Investments	4.19	10.34	15.33	15.3
Other Operating Activities	14.85	11.65	2.55	8.44
Change in Accounts Receivable	4.88	0.99	-2.88	1.73
Change in Inventory	6.25	-0.9	5.59	-12.75
Change in Accounts Payable	-3.65	-2.47	10.23	7.34
Change in Other Net Operating Assets	6.18	9.49	-20.26	-18.06
Operating Cash Flow	3.38	14.49	-28.34	42.08
Operating Cash Flow Growth	-76.69%	-	-	250.98%
Capital Expenditures	-0.26	-0.19	-0.63	-0.36
Investing Cash Flow	-0.26	-0.19	-0.63	-0.36
Short-Term Debt Issued	9.47	1	19.23	-
Total Debt Issued	9.47	1	19.23	-
Short-Term Debt Repaid	-5.62	-3.54	-	-
Long-Term Debt Repaid	-7.17	-6.63	-6.3	-28.9
Total Debt Repaid	-12.79	-10.18	-6.3	-28.9
Net Debt Issued (Repaid)	-3.32	-9.18	12.93	-28.9
Other Financing Activities	-4.52	-7.86	-6.97	-7.46
Financing Cash Flow	-7.84	-17.04	5.95	-36.36
Foreign Exchange Rate Adjustments	0	0.31	-0.14	-0.18
Net Cash Flow	-4.72	-2.43	-23.16	5.18
Free Cash Flow	3.12	14.3	-28.97	41.72
Free Cash Flow Growth	-78.18%	-	-	458.39%
Free Cash Flow Margin	2.75%	9.77%	-20.39%	24.53%
Free Cash Flow Per Share	0.00	0.02	-0.04	0.05
Cash Interest Paid	4.52	7.86	6.97	7.46
Cash Income Tax Paid	-	-0.15	-	0.29
Levered Free Cash Flow	3.34	42.69	-113.36	1.64
Unlevered Free Cash Flow	8.53	48.31	-108.8	5.65
Change in Working Capital	14.3	13.65	-20.65	11.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.